BSE Live
Oct 01, 16:01Prev. Close
906.15
Open Price
902.05
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 01, 15:57Prev. Close
905.85
Open Price
905.00
Bid Price (Qty.)
940.75 (24)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Windlas Biotech (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 10.48 | 10.40 | 10.46 | 10.90 | 6.41 | |
Total Share Capital | 10.48 | 10.40 | 10.46 | 10.90 | 6.41 | |
Reserves and Surplus | 495.31 | 439.89 | 392.20 | 384.23 | 192.58 | |
Total Reserves and Surplus | 495.31 | 439.89 | 392.20 | 384.23 | 192.58 | |
Total Shareholders Funds | 505.79 | 450.29 | 402.67 | 395.13 | 198.99 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 0.00 | 0.00 | 0.11 | 0.44 | 0.83 | |
Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.68 | |
Other Long Term Liabilities | 2.35 | 2.20 | 3.34 | 0.24 | 0.70 | |
Long Term Provisions | 2.88 | 2.32 | 2.02 | 1.57 | 1.37 | |
Total Non-Current Liabilities | 5.24 | 4.52 | 5.46 | 2.25 | 3.59 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 27.12 | 0.11 | 0.34 | 5.68 | 29.41 | |
Trade Payables | 167.24 | 131.11 | 87.38 | 62.90 | 39.93 | |
Other Current Liabilities | 53.51 | 39.40 | 32.72 | 24.75 | 23.80 | |
Short Term Provisions | 1.56 | 0.73 | 0.45 | 0.33 | 0.28 | |
Total Current Liabilities | 249.42 | 171.35 | 120.88 | 93.65 | 93.42 | |
Total Capital And Liabilities | 760.45 | 626.16 | 529.01 | 491.03 | 295.99 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 218.73 | 174.58 | 108.90 | 90.73 | 95.46 | |
Intangible Assets | 4.66 | 4.47 | 0.51 | 0.45 | 0.48 | |
Capital Work-In-Progress | 3.20 | 5.71 | 13.80 | 7.58 | 0.04 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 228.71 | 184.76 | 124.19 | 99.20 | 95.98 | |
Non-Current Investments | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | |
Deferred Tax Assets [Net] | 0.28 | 0.57 | 2.03 | 2.04 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 2.98 | |
Other Non-Current Assets | 6.33 | 9.59 | 49.23 | 8.13 | 2.85 | |
Total Non-Current Assets | 235.32 | 194.92 | 175.47 | 109.39 | 101.84 | |
CURRENT ASSETS | ||||||
Current Investments | 223.37 | 173.44 | 106.51 | 64.82 | 23.14 | |
Inventories | 81.38 | 62.19 | 74.74 | 58.71 | 41.46 | |
Trade Receivables | 166.86 | 136.28 | 116.86 | 110.77 | 79.41 | |
Cash And Cash Equivalents | 15.92 | 30.90 | 25.45 | 113.81 | 30.96 | |
Short Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
OtherCurrentAssets | 37.59 | 28.44 | 29.97 | 33.52 | 19.19 | |
Total Current Assets | 525.13 | 431.24 | 353.54 | 381.63 | 194.16 | |
Total Assets | 760.45 | 626.16 | 529.01 | 491.03 | 295.99 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 2.08 | 15.29 | 14.11 | 3.25 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 3.07 | 7.53 | 6.80 | 6.13 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | 31.10 | 31.33 | 21.78 | 23.21 | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 2.69 | 2.69 | 2.69 | 2.69 | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | -- | -- | 0.03 | 0.03 | 0.03 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 223.37 | 173.44 | 106.51 | -- | 23.14 | |
Current Investments Unquoted Book Value | -- | -- | -- | 64.82 | -- |
10.09.2025
Windlas Biotech Standalone June 2025 Net Sales at Rs 210.09 crore, up 19.95% Y-o-Y
27.05.2025
Windlas Biotech Consolidated March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
23.05.2025
Windlas Biotech Standalone March 2025 Net Sales at Rs 202.71 crore, up 18.34% Y-o-Y
17.02.2025
Windlas Biotech Standalone December 2024 Net Sales at Rs 195.02 crore, up 20.22% Y-o-Y